Spruce Biosciences, Inc. Shares Outstanding (Cover Page)
Spruce Biosciences, Inc. (SPRB) had Shares Outstanding (Cover Page) of 2.87 million shares as of 2026-08-10, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-10: Entity Common Stock, Shares Outstanding 2.87M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 2.75M shares.
- 2026-03-03: Entity Common Stock, Shares Outstanding 1.37M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 1.07M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 2.87M shares 10-Q · filed 2026-08-12 |
| 2026-05-11 | 2.75M shares 10-Q · filed 2026-05-13 |
| 2026-03-03 | 1.37M shares 10-K · filed 2026-03-09 |
| 2025-11-07 | 1.07M shares 10-Q · filed 2025-11-10 |
| 2025-08-12 | 563.04K shares 10-Q · filed 2025-08-14 |
| 2025-05-01 | 42.23M shares 10-Q · filed 2025-05-06 |
| 2025-04-11 | 42.23M shares 10-K · filed 2025-04-15 |
| 2024-11-08 | 41.30M shares 10-Q · filed 2024-11-12 |
| 2024-08-08 | 41.30M shares 10-Q · filed 2024-08-12 |
| 2024-05-09 | 41.15M shares 10-Q · filed 2024-05-13 |
| 2024-03-14 | 41.15M shares 10-K · filed 2024-03-18 |
| 2023-11-09 | 40.71M shares 10-Q · filed 2023-11-13 |
| 2023-08-10 | 40.71M shares 10-Q · filed 2023-08-14 |
| 2023-05-11 | 39.75M shares 10-Q · filed 2023-05-15 |
| 2023-03-10 | 39.75M shares 10-K · filed 2023-03-16 |
| 2022-11-04 | 23.56M shares 10-Q · filed 2022-11-10 |
| 2022-08-08 | 23.56M shares 10-Q · filed 2022-08-10 |
| 2022-05-06 | 23.49M shares 10-Q · filed 2022-05-11 |
| 2022-03-11 | 23.49M shares 10-K · filed 2022-03-14 |
| 2021-11-12 | 23.46M shares 10-Q · filed 2021-11-15 |
| 2021-08-04 | 23.38M shares 10-Q · filed 2021-08-10 |
| 2021-05-10 | 23.33M shares 10-Q · filed 2021-05-12 |
| 2021-03-19 | 23.30M shares 10-K · filed 2021-03-22 |
| 2020-11-09 | 23.21M shares 10-Q · filed 2020-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |